Trial of prevention of preterm birth in pregnancy after preterm birth by progesterone

Trial of prevention of preterm birth in pregnancy after preterm birth by progesterone - Trial of prevention of preterm birth in pregnancy after preterm birth by progesterone

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031586

Enrollment

100

Registered

2018-03-05

Start date

2018-02-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy after preterm birth

Interventions

Injection of progesterone 250mg into muscle once weekly between 16 and 36 weeks of gestations

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: pregnancy women after preterm birth

Exclusion criteria

Exclusion criteria: 1) prior preterm birth by induction for obstetrics complication 2) contraindication of progesterone 3) multiple pregnancy 4) fetus of severe anomaly or abnormal chromosome

Design outcomes

Primary

Measure	Time frame
rate of preterm birth	—

Countries

Japan

Contacts

Public ContactMika Mizoguchi

Wakayama Medical University Department of Obstetrics and Gynecology

ma-mika@wakayama-med.ac.jp073-441-0631

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026